Early phase studies using a single antigen such as MUC1 or HER2 in colorectal adenoma patients with resected polyps or in DCIS respectively, showed safety and induction of antigen specific immune responses (NCT00773097) [26, 66]. Here, ERBB2 is linked to ductal breast carcinoma in situ.